G 
Gilead Sciences GILD · USD
Health Care · Biotechnology · US listing · 🇺🇸 United States
S&P 500Nasdaq-100
169.32
+1.46%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$29.44bn
FY2016FY2025
Net income
$8.51bn
FY2016FY2025
Free cash flow
$9.46bn
FY2016FY2025
Shareholders' equity
$22.70bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.44bn | $28.75bn | $27.12bn | $27.28bn | $27.30bn | $24.69bn | $22.45bn | $22.13bn | $26.11bn | $30.39bn |
| Research and development | $5.80bn | $5.91bn | $5.72bn | $4.98bn | $4.60bn | $5.04bn | $4.05bn | $3.92bn | $3.73bn | $5.10bn |
| Operating income | $10.82bn | $1.67bn | $7.61bn | $7.33bn | $9.92bn | $4.07bn | $6.16bn | $8.20bn | $14.12bn | $17.63bn |
| Net income | $8.51bn | $480.0m | $5.67bn | $4.59bn | $6.22bn | $123.0m | $5.39bn | $5.46bn | $4.63bn | $13.50bn |
| Diluted earnings per share | 6.79 | 0.38 | 4.51 | 3.63 | 4.93 | 0.10 | 4.23 | 4.20 | 3.54 | 10.17 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $59.02bn | $58.99bn | $62.13bn | $63.17bn | $67.95bn | $68.41bn | $61.63bn | $63.67bn | $70.28bn | $56.98bn |
| Cash and short-term investments | $9.61bn | $11.57bn | $7.26bn | $6.38bn | $6.52bn | $7.41bn | $24.35bn | $30.09bn | $25.51bn | $32.38bn |
| Total liabilities | $36.41bn | $39.75bn | $39.38bn | $41.96bn | $46.89bn | $50.19bn | $38.98bn | $42.14bn | $49.78bn | $37.61bn |
| Debt | $24.94bn | $26.71bn | $24.99bn | $25.23bn | $26.70bn | $31.40bn | $24.59bn | $27.32bn | $33.54bn | $26.35bn |
| Shareholders' equity | $22.70bn | $19.33bn | $22.83bn | $21.24bn | $21.07bn | $18.20bn | $22.52bn | $21.39bn | $20.44bn | $19.36bn |
| Shares outstanding | 1,253m | 1,259m | 1,256m | 1,264m | 1,262m | 1,259m | 1,273m | 1,299m | 1,307m | 1,327m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $10.02bn | $10.83bn | $8.01bn | $9.07bn | $11.38bn | $8.17bn | $9.14bn | $8.40bn | $11.90bn | $17.05bn |
| Capital spending | −$563.0m | −$523.0m | −$585.0m | −$728.0m | −$579.0m | −$650.0m | −$825.0m | −$924.0m | −$590.0m | −$748.0m |
| Free cash flow | $9.46bn | $10.30bn | $7.42bn | $8.34bn | $10.80bn | $7.52bn | $8.32bn | $7.48bn | $11.31bn | $16.30bn |
| Dividends paid | −$4.00bn | −$3.92bn | −$3.81bn | −$3.71bn | −$3.60bn | −$3.45bn | −$3.22bn | −$2.97bn | −$2.73bn | −$2.46bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.80bn | $6.96bn | $7.92bn | $7.77bn | $7.08bn | $6.67bn | $7.57bn | $7.54bn |
| Operating income | −$10.39bn | $2.69bn | $2.99bn | $3.50bn | $2.47bn | $2.24bn | $2.45bn | $1.19bn |
| Net income | −$10.50bn | $2.02bn | $2.18bn | $3.05bn | $1.96bn | $1.31bn | $1.78bn | $1.25bn |
| Diluted earnings per share | -8.44 | 1.63 | 1.74 | 2.44 | 1.56 | 1.05 | 1.42 | 1.00 |
| Cash from operations | $3.57bn | $2.54bn | $3.33bn | $4.11bn | $827.0m | $1.76bn | $2.98bn | $4.31bn |
| Capital spending | −$117.0m | −$117.0m | −$205.0m | −$147.0m | −$107.0m | −$104.0m | −$147.0m | −$141.0m |
| Free cash flow | $3.46bn | $2.43bn | $3.12bn | $3.96bn | $720.0m | $1.65bn | $2.83bn | $4.17bn |
| Total assets | $49.36bn | $56.28bn | $59.02bn | $58.53bn | $55.72bn | $56.43bn | $58.99bn | $54.52bn |
| Cash and short-term investments | $3.18bn | $7.64bn | $9.61bn | $7.35bn | $5.21bn | $7.93bn | $11.57bn | $6.70bn |
| Debt | $26.25bn | $22.17bn | $24.94bn | $24.94bn | $24.95bn | $24.95bn | $26.82bn | $23.25bn |
| Shareholders' equity | $11.83bn | $23.52bn | $22.70bn | $21.54bn | $19.68bn | $19.16bn | $19.33bn | $18.47bn |
Financial ratios
Data as of 5 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 36.8% | 5.8% | 28.0% | 26.9% | 36.3% | 16.5% |
| Net margin | 28.9% | 1.7% | 20.9% | 16.8% | 22.8% | 0.5% |
| Return on equity | 37.5% | 2.5% | 24.8% | 21.6% | 29.5% | 0.7% |
| Return on assets | 14.4% | 0.8% | 9.1% | 7.3% | 9.2% | 0.2% |
| Free cash flow yield | 5.6% | 6.0% | 4.5% | 5.1% | 6.3% | 4.6% |
| Revenue growth | 2.4% | 6.0% | -0.6% | -0.1% | 10.6% | 10.0% |
| Earnings growth | 1672.9% | -91.5% | 23.4% | -26.2% | 4961.0% | -97.7% |
| Current ratio | 1.55x | 1.60x | 1.43x | 1.29x | 1.27x | 1.40x |
| Debt to equity | 1.10x | 1.38x | 1.09x | 1.19x | 1.27x | 1.73x |
| Equity ratio | 38.5% | 32.8% | 36.8% | 33.6% | 31.0% | 26.6% |
| Interest coverage | 10.57x | 1.71x | 8.06x | 7.84x | 9.91x | 4.14x |
| R&D as a share of sales | 19.7% | 20.5% | 21.1% | 18.2% | 16.9% | 20.4% |
| Buybacks as a share of market value | 0.5% | -0.2% | 0.6% | -0.2% | -0.2% | 1.1% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.6% | 3.6% | -1.0% |
| Operating income | 13.9% | 21.6% | -6.9% |
| Net income | 22.8% | 133.3% | -7.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 21.5% | 24.4% | 25.2% | 36.8% |
| Net margin | 15.4% | 17.1% | 15.6% | 24.4% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 18.1 | 242.3 | 18.0 | 23.6 | 14.7 | — | 15.4 | 14.9 | 20.2 | 7.0 |
| Price to sales | 5.2 | 4.0 | 3.8 | 4.0 | 3.4 | 3.0 | 3.7 | 3.7 | 3.6 | 3.1 |
Market value over time
31 Oct 2016 to 4 Sept 2026, in USD
$98.59bn$187.69bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 34% | 14% | -8% | 19% | 24% | -12% | 4% | -13% | -0% | -24% |
Dividends and splits
Per share, in the currency the company pays
Paid for 11 years. Last went ex-dividend on 15 Dec 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 3.28 | 3.16 | 3.08 | 3.00 | 2.92 | 2.84 | 2.72 | 2.52 |
- 2-for-1 split · 28 Jan 2013
- 2-for-1 split · 25 Jun 2007
- 2-for-1 split · 7 Sept 2004
- 2-for-1 split · 8 Mar 2002
- 2-for-1 split · 22 Feb 2001
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.